![]() |
市场调查报告书
商品编码
1930137
全球疝气修补网片市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考量因素以及未来预测(2026-2034)Hernia Mesh Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
预计2025年全球疝气修补网片市场规模将达24亿美元,从2026年的25.3亿美元成长至2034年的44.2亿美元,预测期内复合年增长率(CAGR)为7.22%。北美预计将在2025年占市场主导地位,市场占有率达35.91%,这主要得益于腹腔镜疝气修补术的日益普及以及主要医疗器材製造商的强大市场地位。
疝气修补网片是一种外科植入物,用于在疝气修补手术中加固薄弱的组织。全球疝气疾病发生率的不断上升以及人们对网片修补术日益增长的偏好,是推动市场扩张的重要因素。
市场驱动因素
疝气疾病发生率的上升是市场成长的主要驱动因素。根据本报告引用的数据,2019年全球新增疝气病例达1,302万例,其中86.3%为男性。疝气负担的加重促使全球手术介入次数的增加。
此外,大多数疝气修补手术都使用网片。全球约80%的疝气手术都使用疝气修补网片,显着推动了产品需求。市场参与者致力于推出技术先进的生物材料网片产品,也进一步加速了这些产品在医院和手术中心的应用。
新冠疫情的影响
在新冠疫情期间,疝气修补网片市场经历了短暂的下滑,主要原因是择期手术和非紧急手术的延迟。由于医疗机构优先处理急诊,手术数量减少,导致产品需求下降。
然而,随着外科手术的恢復,市场在接下来的几年里强劲復苏。疝气修补手术量的增加以及对网片修復解决方案需求的恢復,为製造商带来了收入的成长,从而支撑了市场的稳定和復苏。
市场趋势
影响市场的关键趋势是专注于新产品的推出。製造商正在开发具有更高机械强度、更低復发率和更强生物相容性的先进网片产品。
由于可吸收网片能够改善临床疗效并减少併发症,其引入引起了广泛关注。老牌企业和新进业者不断创新,改善了患者获得先进疝气修补方案的机会,从而促进了整体市场成长。
限制因子
儘管成长潜力巨大,疝气修补网片使用相关的併发症仍然是主要限制因素。这些併发症包括疝气復发、感染、沾黏、肠阻塞和慢性疼痛。
根据本报告引用的数据,网片修补术后的疝气復发率高达 30%。此外,对不良患者预后的担忧促使人们寻求替代的非网片修补技术,这可能会在某些情况下限制网片的应用。
依产品划分:
市场依产品分为生物网片和合成网片。预计到 2026 年,生物网片将占 63.23% 的市场占有率,这主要得益于其卓越的机械强度和较低的復发率。由于其成本效益和易得性,合成网片预计将保持稳定成长。
依类型划分:
市场依疝气类型分为腹股沟疝气、股疝气、腹壁疝气和其他类型。由于每年进行的腹股沟疝气手术数量众多,腹股沟疝气细分市场预计将占领先地位,到 2026 年将占 52.5% 的市场占有率。
依最终使用者划分:
由于疝气手术数量的增加和先进的手术基础设施,医院和门诊手术中心 (ASC) 细分市场预计将占主导地位,到 2026 年将占 72.24% 的市场占有率。由于人们对疝气的认识不断提高,以及手术效率的提升,专科诊所预计将稳步增长。
北美将占市场领先地位,2025 年市场规模将达到 8.6 亿美元,预计到 2026 年,美国市场规模将达到 8.8 亿美元。由于疝气修补手术中网片的使用率较高,欧洲将维持较大的市场占有率,预计到 2026 年,德国市场规模将达到 1.6 亿美元。
亚太地区预计将迎来显着成长,这主要得益于疝气盛行率和手术量的上升。预计到 2026 年,中国市场规模将达到 2.4 亿美元,日本达到 1.4 亿美元,印度达到 1 亿美元。
The global hernia mesh devices market was valued at USD 2.4 billion in 2025 and is projected to grow from USD 2.53 billion in 2026 to USD 4.42 billion by 2034, registering a CAGR of 7.22% during the forecast period. North America dominated the market with a 35.91% share in 2025, supported by widespread adoption of laparoscopic hernia repair procedures and the strong presence of key medical device manufacturers.
Hernia mesh devices are surgical implants used to reinforce weakened tissue during hernia repair surgeries. The increasing global prevalence of hernia conditions and the rising preference for mesh-based surgical repairs are significantly contributing to market expansion.
Market Drivers
The rising prevalence of hernia disorders is a primary driver fueling market growth. According to data referenced in the report, global incident cases of hernia reached 13.02 million in 2019, with 86.3% of cases observed in males. The growing burden of hernia is leading to an increased number of surgical interventions worldwide.
Furthermore, a large proportion of hernia repair surgeries utilize mesh devices. Approximately 80% of hernia surgeries globally involve hernia mesh, which significantly boosts product demand. The increasing focus of market players on launching technologically advanced and biomaterial-based mesh products is further accelerating adoption across hospitals and surgical centers.
COVID-19 Impact
The hernia mesh devices market witnessed a temporary decline during the COVID-19 pandemic, primarily due to the postponement of elective and non-emergency surgeries. Healthcare facilities prioritized emergency care, leading to reduced procedural volumes and lower product demand.
However, the market recovered strongly in subsequent years with the resumption of surgical procedures. Manufacturers experienced revenue growth due to increased hernia surgeries and renewed demand for mesh-based repair solutions, supporting market stabilization and recovery.
Market Trends
A key trend shaping the market is the increasing focus on new product launches. Manufacturers are developing advanced mesh products with improved mechanical strength, reduced recurrence rates, and enhanced biocompatibility.
The introduction of biological and resorbable mesh devices has gained traction due to better clinical outcomes and reduced complications. Continuous innovation by established companies and new entrants is improving patient access to advanced hernia repair solutions and strengthening overall market growth.
Restraining Factors
Despite strong growth potential, the market faces restraints due to complications associated with hernia mesh usage. These include hernia recurrence, infection, adhesion, bowel obstruction, and chronic pain.
Data referenced in the report indicates a hernia recurrence rate of up to 30% following mesh-based surgeries. Additionally, patient concerns regarding adverse outcomes have encouraged the exploration of alternative non-mesh repair techniques, which may limit widespread adoption in certain cases.
By Product:
The market is segmented into biological mesh and synthetic mesh. The biological mesh segment dominated with a 63.23% share in 2026, driven by superior mechanical strength and reduced recurrence rates. Synthetic mesh is expected to grow steadily due to cost-effectiveness and wider availability.
By Type:
Based on hernia type, the market includes inguinal, femoral, ventral, and others. The inguinal segment led with a 52.5% share in 2026, supported by the high number of inguinal hernia surgeries performed annually.
By End User:
The hospitals & ASCs segment dominated the market with a 72.24% share in 2026, owing to the rising volume of hernia surgeries and advanced surgical infrastructure. Specialty clinics are expected to grow steadily with increasing awareness and procedural efficiency.
North America led the market with a value of USD 0.86 billion in 2025, and the U.S. market is projected to reach USD 0.88 billion by 2026. Europe holds a substantial market share due to high mesh usage rates in hernia repair surgeries, with Germany projected at USD 0.16 billion by 2026.
The Asia Pacific region is expected to grow at a significant rate, driven by rising hernia prevalence and increasing surgical volumes. By 2026, China is projected to reach USD 0.24 billion, Japan USD 0.14 billion, and India USD 0.10 billion.
Competitive Landscape
Key players operating in the market include Johnson & Johnson Services, Medtronic, BD, B. Braun SE, Baxter, W. L. Gore & Associates, Integra LifeSciences, and COOK. These companies focus on mergers, acquisitions, capacity expansion, and product innovation to strengthen their market position.
Conclusion
The global hernia mesh devices market is expected to witness steady growth from 2025 to 2034, driven by the rising prevalence of hernia conditions, increasing surgical volumes, and advancements in mesh technology. While concerns regarding complications and recurrence remain, continuous innovation, expanding adoption of biological mesh, and growing healthcare infrastructure are expected to sustain market momentum. By 2034, the market is projected to reach USD 4.42 billion, highlighting the critical role of hernia mesh devices in modern surgical care.
Segmentation By Product
By Type
By End-user
By Region